Cargando…

Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib

To improve the outcome of cancer chemotherapy, strategies to enhance the efficacy of anticancer drugs are required. Sorafenib is the only drug to prolong overall survival of the patients with hepatocellular carcinoma (HCC), however, the outcome is still not satisfactory. Retinoids, vitamin A derivat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishijima, Naoki, Kanki, Keita, Shimizu, Hiroki, Shiota, Goshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452157/ https://www.ncbi.nlm.nih.gov/pubmed/25683251 http://dx.doi.org/10.1111/cas.12633

Ejemplares similares

miR‐181a induces sorafenib resistance of hepatocellular carinoma cells through downregulation of RASSF1 expression
por: Azumi, Junya, et al.
Publicado: (2016)

Targeting AMP‐activated kinase impacts hepatocellular cancer stem cells induced by long‐term treatment with sorafenib
por: Bort, Alicia, et al.
Publicado: (2019)

ATRA sensitized the response of hepatocellular carcinoma to Sorafenib by downregulation of p21-activated kinase 1
por: Wang, Kai, et al.
Publicado: (2023)

Identification of the Genes Chemosensitizing Hepatocellular Carcinoma Cells to Interferon-α/5-Fluorouracil and Their Clinical Significance
por: Sakabe, Tomohiko, et al.
Publicado: (2013)

Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation
por: Ionta, M., et al.
Publicado: (2012)

Retinoic acid stimulates the differentiation of PC12 cells that are deficient in cAMP-dependent protein kinase
Publicado: (1991)

AMP-Activated Protein Kinase Suppresses the In Vitro and In Vivo Proliferation of Hepatocellular Carcinoma
por: Cheng, Jidong, et al.
Publicado: (2014)

Metformin Sensitizes Leukemia Cells to Vincristine via Activation of AMP-activated Protein Kinase
por: Yi, Yong, et al.
Publicado: (2017)

Glutamine synthetase mediates sorafenib sensitivity in β-catenin-active hepatocellular carcinoma cells
por: Sohn, Bo Hwa, et al.
Publicado: (2018)

Activation of AMP-activated protein kinase (AMPK) through inhibiting interaction with prohibitins
por: Kanagaki, Shuhei, et al.
Publicado: (2023)

A Highly Sensitive Non-Radioactive Activity Assay for AMP-Activated Protein Kinase (AMPK)
por: Yan, Yan, et al.
Publicado: (2017)

AMP-Activated Protein Kinase Signalling
por: Neumann, Dietbert, et al.
Publicado: (2019)

The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma
por: Jiang, Xue, et al.
Publicado: (2019)

Involvement of Hypothalamic AMP-Activated Protein Kinase in Leptin-Induced Sympathetic Nerve Activation
por: Tanida, Mamoru, et al.
Publicado: (2013)

Activation of AMP-activated protein kinase attenuates hepatocellular carcinoma cell adhesion stimulated by adipokine resistin
por: Yang, Chen-Chieh, et al.
Publicado: (2014)

Resminostat induces changes in epithelial plasticity of hepatocellular carcinoma cells and sensitizes them to sorafenib-induced apoptosis
por: Soukupova, Jitka, et al.
Publicado: (2017)

Activation of the CRABPII/RAR pathway by curcumin induces retinoic acid mediated apoptosis in retinoic acid resistant breast cancer cells
por: Thulasiraman, Padmamalini, et al.
Publicado: (2017)

Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
por: Shen, Y-C, et al.
Publicado: (2013)

All-trans retinoic acid modulates mitogen-activated protein kinase pathway activation in human scleral fibroblasts through retinoic acid receptor beta
por: Huo, Lijun, et al.
Publicado: (2013)

Polymer Nanoformulation of Sorafenib and All-Trans Retinoic Acid for Synergistic Inhibition of Thyroid Cancer
por: Li, Shijie, et al.
Publicado: (2020)

Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Is Reversed by SIRT1
por: Garten, Antje, et al.
Publicado: (2019)

CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic Cell Death
por: Ding, Bisha, et al.
Publicado: (2021)

Adiponectin inhibits neutrophil apoptosis via activation of AMP kinase, PKB and ERK 1/2 MAP kinase
por: Rossi, Alessandra, et al.
Publicado: (2013)

Ginsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats
por: Shen, Ling, et al.
Publicado: (2015)

Opposing Activity Changes in AMP Deaminase and AMP-Activated Protein Kinase in the Hibernating Ground Squirrel
por: Lanaspa, Miguel A., et al.
Publicado: (2015)

Hibiscus Anthocyanins Extracts Induce Apoptosis by Activating AMP-Activated Protein Kinase in Human Colorectal Cancer Cells
por: Tsai, Ming-Chang, et al.
Publicado: (2023)

Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib
por: Jiang, Zhonghao, et al.
Publicado: (2023)

Redox Regulation of the AMP-Activated Protein Kinase
por: Han, Yingying, et al.
Publicado: (2010)

Identification of genes involved in the regulation of TERT in hepatocellular carcinoma
por: Amisaki, Masataka, et al.
Publicado: (2019)

Synthesis and anti-hepatocellular carcinoma activity of aminopyridinol–sorafenib hybrids
por: Awasthi, Bhuwan Prasad, et al.
Publicado: (2021)

Regulation of AMP-activated protein kinase by natural and synthetic activators
por: Grahame Hardie, David
Publicado: (2016)

Elevated basal AMP-activated protein kinase activity sensitizes colorectal cancer cells to growth inhibition by metformin
por: Morrison, Kaitlin R., et al.
Publicado: (2023)

Identification of the small molecule compound which induces hepatic differentiation of human mesenchymal stem cells
por: Itaba, Noriko, et al.
Publicado: (2015)

Targeting to the non-genomic activity of retinoic acid receptor-gamma by acacetin in hepatocellular carcinoma
por: Zeng, Wenjun, et al.
Publicado: (2017)

AMP-activated protein kinase determines apoptotic sensitivity of cancer cells to ginsenoside-Rh2
por: Kim, Min-Jung, et al.
Publicado: (2013)

AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest
por: Zhou, Wei, et al.
Publicado: (2021)

Fenretinide-induced apoptosis of Huh-7 hepatocellular carcinoma is retinoic acid receptor β dependent
por: Bu, Pengli, et al.
Publicado: (2007)

Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis
por: Li, Yan, et al.
Publicado: (2023)

Antidiabetic effects of betulinic acid mediated by the activation of the AMP-activated protein kinase pathway
por: Song, Tae-Jun, et al.
Publicado: (2021)

Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid
por: Qin, Xian-Yang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eu04fnmfd0h8v6pv5nsjher3pa